Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overactive detrusor.

J Sullivan1, P Abrams

  • 1Department of Urology, Bristol Urological Institute, Southmead Hospital, UK. edu@bui.ac.uk

Current Opinion in Urology
|August 25, 1999
PubMed
Summary
This summary is machine-generated.

Detrusor overactivity presents a significant clinical challenge. Recent advancements in understanding its causes and developing novel treatments, including neuromodulation and bladder augmentation, offer improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are We Able to Optimize Outcomes and Predict Complications in Pelvic Floor Surgery With a Better Understanding of Hormonal, Microbial and Other Factors? A Report From the ICI-RS 2024.

Neurourology and urodynamics·2024
Same author

Biomechanical improvements in gait following medial pivot knee implant surgery.

Clinical biomechanics (Bristol, Avon)·2024
Same author

A Percutaneous Technique for Reduction and Internal Fixation of Displaced Intra-Articular Calcaneal Fractures.

JBJS essential surgical techniques·2021
Same author

V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimens.

Antiviral chemistry & chemotherapy·2021
Same author

Fenfluramine for treatment-resistant epilepsy in Dravet syndrome and other genetically mediated epilepsies.

Drugs of today (Barcelona, Spain : 1998)·2021
Same author

Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study.

The British journal of dermatology·2020
Same journal

Role and relevance of genetic testing in patients with kidney stones: a review from EAU Section of Endourology.

Current opinion in urology·2026
Same journal

Advances in evaluating and delivering nontechnical skills training: The use of simulation, robotics, artificial intelligence and virtual reality.

Current opinion in urology·2026
Same journal

Educating for a sustainable future: faculty and student perspectives and a review of environmental sustainability in medical education - an EAU endourology study.

Current opinion in urology·2026
Same journal

Shaping the future of endourology: role of education, simulation and uro-technology: a scoping review by the EAU Section of Endourology.

Current opinion in urology·2026
Same journal

A review of emerging technologies and techniques for percutaneous nephrolithotomy access.

Current opinion in urology·2026
Same journal

Artificial intelligence in kidney cancer: a review of clinical applications across the disease spectrum.

Current opinion in urology·2026
See all related articles

Area of Science:

  • Urology
  • Nephrology
  • Neurology

Background:

  • Detrusor overactivity is a common condition causing significant challenges for physicians across multiple specialties.
  • Understanding the underlying pathogenesis of detrusor overactivity has been progressing steadily.

Purpose of the Study:

  • To review recent progress in understanding the pathogenesis of detrusor overactivity.
  • To highlight advances in treatment strategies for detrusor overactivity.

Main Methods:

  • Review of current literature on detrusor overactivity.
  • Analysis of emerging treatment modalities and drug delivery systems.

Main Results:

  • Progress in understanding the pathogenesis of detrusor overactivity is ongoing.

Related Experiment Videos

  • New therapeutic agents and improved drug delivery methods are being developed.
  • Neuromodulation techniques show significant promise.
  • Innovations in bladder augmentation aim for reduced morbidity.

    • Conclusions:

    • Continued research into pathogenesis is crucial.
    • Novel treatments, including neuromodulation and advanced bladder augmentation, offer hope for managing detrusor overactivity with improved outcomes and lower morbidity.